BELITE BIO, INC: management transactions · United States · SEC (Form 4) Browse the full insider trade history of BELITE BIO, INC, a listed equity based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Market capitalisation: €5.7bn. The latest transaction was disclosed on 5 May 2026 (Cession). Among the most active insiders: MATA NATHAN L.. Every trade is accessible without an account.
€410,668
17 ops.
Sell Volume
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 5 May 2026
All Executives17 Thresholds0 Prospectus0 Other0
Declarations 17 total
▼ Chief Scientific Officer · Executives · 4 May 2026
32 shares @ US$153.495 1.0% of flow American depositary share SEC:0001193125-26-206456:0
▼ Chief Scientific Officer · Executives · 4 May 2026
236 shares @ US$154.2375 7.6% of flow American depositary share SEC:0001193125-26-206456:1
▼ Chief Scientific Officer · Executives · 4 May 2026
325 shares @ US$155.206 10.5% of flow American depositary share SEC:0001193125-26-206456:2
▼ Chief Scientific Officer · Executives · 4 May 2026
235 shares @ US$156.5677 7.7% of flow American depositary share SEC:0001193125-26-206456:3
▼ Chief Scientific Officer · Executives · 4 May 2026
172 shares @ US$157.4904 5.6% of flow American depositary share SEC:0001193125-26-206456:4
▼ Chief Scientific Officer · Executives · 27 Apr 2026
44 shares @ US$160.8345 1.5% of flow American depositary share SEC:0001193125-26-187224:0
▼ Chief Scientific Officer · Executives · 27 Apr 2026
280 shares @ US$161.6211 9.4% of flow American depositary share SEC:0001193125-26-187224:1
▼ Chief Scientific Officer · Executives · 27 Apr 2026
231 shares @ US$162.3775 7.8% of flow American depositary share SEC:0001193125-26-187224:2
▼ Chief Scientific Officer · Executives · 27 Apr 2026
409 shares @ US$163.5573 13.9% of flow American depositary share SEC:0001193125-26-187224:3
▼ Chief Scientific Officer · Executives · 27 Apr 2026
36 shares @ US$164.0717 1.2% of flow American depositary share SEC:0001193125-26-187224:4
▼ Chief Scientific Officer · Executives · 20 Apr 2026
284 shares @ US$162.7552 9.6% of flow American depositary share SEC:0001193125-26-167281:0
▼ Chief Scientific Officer · Executives · 20 Apr 2026
524 shares @ US$163.5193 17.7% of flow American depositary share SEC:0001193125-26-167281:1
▼ Chief Scientific Officer · Executives · 20 Apr 2026
124 shares @ US$164.4009 4.2% of flow American depositary share SEC:0001193125-26-167281:2
▼ Chief Scientific Officer · Executives · 20 Apr 2026
40 shares @ US$165.2935 1.4% of flow American depositary share SEC:0001193125-26-167281:3
▼ Chief Scientific Officer · Executives · 20 Apr 2026
3 shares @ US$166.905 0.1% of flow American depositary share SEC:0001193125-26-167281:4
▼ Chief Scientific Officer · Executives · 20 Apr 2026
16 shares @ US$167.165 0.6% of flow American depositary share SEC:0001193125-26-167281:5
▼ Chief Scientific Officer · Executives · 20 Apr 2026
9 shares @ US$168.35 0.3% of flow American depositary share SEC:0001193125-26-167281:6